Created in 2014 (Japan), Abilify MyCite own 146 sister brands and 17477 competing brands. Abilify MyCite is owned by OTSUKA HOLDING CO LTD, listed on the stock exchange of Francfort The ISIN, the company's International Securities Identification Number, is JP3188220002. Abilify MyCite belongs to the Drug Manufacturers business sector.

Abilify MyCite is a brand of OTSUKA HOLDING CO LTD (OS1) Share price

International deposit : 2014 Business sector Drug Manufacturers

Share price and profitability of the share OTSUKA HOLDING CO LTD (Abilify MyCite)

Buy OTSUKA HOLDING CO LTD share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 37.00

Portfolio valuation
OTSUKA HOLDING CO LTD (Abilify MyCite) over 5 years* EUR 44.40

Stock market history OTSUKA HOLDING CO LTD (Abilify MyCite)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
OTSUKA HOLDING CO LTD

Visterra
Visterra
Neurovance
Neurovance
Otsuka
Otsuka
See more brands of OTSUKA HOLDING CO LTD

Rival brands
Abilify MyCite

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS